Touyun Biotech Group (HKSE:01332) Margin of Safety % (DCF FCF Based): N/A (As of Jul. 05, 2026)


HKSE:01332 Touyun Biotech Group Ltd HKSE:01332
25 GF Score
Price HK$0.16
GF Value HK$0.16
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Touyun Biotech Group Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Touyun Biotech Group's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

HKSE:01332 vs SW, PKG, IP: Margin of Safety % (DCF FCF Based) Comparison

For the Packaging & Containers subindustry, Touyun Biotech Group's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Touyun Biotech Group Margin of Safety % (DCF FCF Based) vs Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Touyun Biotech Group's Margin of Safety % (DCF FCF Based) falls into.


HKSE:01332
25GF Score
Touyun Biotech Group Ltd HKSE:01332
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?

Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be undervalued. The current stock price of HK$0.16 is trading 1.3% below its estimated GF Value™ of HK$0.16. GuruFocus considers Touyun Biotech Group to be Fairly Valued.

Key valuation signals for HKSE:01332:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: HK$0.16 vs. price of HK$0.16 (1.3% below fair value)
  • GF Score™: 25/100 with 6 warning signs

No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Touyun Biotech Group Business Description

Address 6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
25GF Score

Get the complete analysis for HKSE:01332

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.16
Price
HK$0.16
GF Value